Sign Up to like & get
recommendations!
0
Published in 2019 at "ACS chemical neuroscience"
DOI: 10.1021/acschemneuro.9b00199
Abstract: Misfolded amyloid-β (Aβ) is the key biomarker of Alzheimer's disease (AD), and discoveries of fluorescence chemicals visualizing such Aβ aggregates in the brain have made major contributions in postmortem and antemortem diagnosis of the disorder.…
read more here.
Keywords:
detect insoluble;
fluorescence;
fluorescence chemicals;
chemicals detect ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Neuropathology and Applied Neurobiology"
DOI: 10.1111/nan.12895
Abstract: According to the instructions for authors, short communications should be published without abstract.
read more here.
Keywords:
resistant amyloid;
dimers resistant;
prion conversion;
soluble amyloid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms22126355
Abstract: A large body of clinical and nonclinical evidence supports the role of neurotoxic soluble beta amyloid (amyloid, Aβ) oligomers as upstream pathogenic drivers of Alzheimer’s disease (AD). Recent late-stage trials in AD that have evaluated…
read more here.
Keywords:
oligomers drive;
neurotoxic soluble;
disease progression;
amyloid oligomers ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23105794
Abstract: Soluble amyloid β (Aβ) oligomers have been shown to be highly toxic to neurons and are considered to be a major cause of the neurodegeneration underlying Alzheimer’s disease (AD). That makes soluble Aβ oligomers a…
read more here.
Keywords:
small molecule;
disease;
alzheimer disease;
soluble amyloid ... See more keywords